Jetstar has responded to a consumer class action over flights cancelled during the COVID-19 pandemic, denying that it used “unfair tactics” to avoid providing the refunds customers say they were owed.

In the latest example of a judgment being overturned for uncritical copying and pasting, a judge has quashed the AAT’s decision to cancel a migrant’s student visa for failing to bring an independent ...

Boral has won a legal challenge to its former CEO facing cross-examination in a shareholder class action trial over an email referring to a confidential EY report.

" data-display-label="0" data-show-count="1" data-bookmark-label="Save" data-bookmarked-label="Saved" data-loggedin="0" data-type="post" data-object_id="311820" class="cbxwpbkmarktrig ...

A judge has approved a $57.5 million settlement in a class action against ANZ over credit card interest, including allowing the funder to recoup $1.2 million in after-the-event insurance costs.

An intellectual property firm has lost its legal challenge to Apple’s bid to patent its method of authentication on electronic devices, including smartphones. An Australian fashion designer has asked ...

Two Queensland solicitors have scored partial wins in their decades-long disputes with the tax office because of the Administrative Appeals Tribunal’s “wholesale failure” to give proper reasons.

Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.

An Australian fashion designer has asked the High Court to overturn a Full Court win for singer Katy Perry in a long-running trade mark dispute, saying the court’s findings “wrongly privilege the ...

Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.

Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.

The government has proposed tougher penalties to crack down on the improper use of legal professional privilege claims in Commonwealth investigations.